Clinical trial
The PrOMISE Study: PegvisOMant and the Immune SystEm
NCT05069324 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The PrOMISE Study: PegvisOMant and the Immune SystEm
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 29, 2020
- Completion date
- December 15, 2024
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.